|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Interest earned on marketable securities held in Trust Account | ||
| Interest and dividends earned on cash and investments held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Short-term prepaid insurance | ||
| Due to Sponsor | ||
| Accounts payable and accrued expenses | ||
| Income taxes payable | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Cash withdrawn from Trust Account to pay income taxes | ||
| Cash withdrawn from Trust Account in connection with redemption | ||
| Investment of cash into Trust Account | ||
| Net cash provided by (used in) investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of units, net of underwriting discounts paid | ||
| Proceeds from sale of private placement units | ||
| Proceeds from promissory note | ||
| Repayment of promissory note | ||
| Advances from related party | ||
| Repayment of advances from related party | ||
| Payment of offering costs | ||
| Redemptions of common stock | ||
| Net cash used in financing activities | ||
| Net Change in Cash and cash equivalents and Restricted Cash | ||
| Cash and cash equivalents and Restricted Cash – Beginning of period | ||
| Cash and cash equivalents and Restricted Cash – End of period | ||
| Cash | ||
| Cash – restricted | ||
| Non-Cash investing and financing activities: | ||
| Issuance of representative shares | ||
| Representative warrants deferred offering cost allocation | ||
| Remeasurement of Common Stock subject to possible redemption | ||
| Excise tax payable attributable to redemption of Common Stock |
Loading...
